Skip to main content
Retour
Watch Compare

Eledon Pharmaceuticals, Inc.

Qualité des données : 83%
ELDN
Nasdaq Manufacturing Chemicals
3,12 €
▼ 0,01 € (-0,32%)
Cap. Boursière: 248,44 M
Prix
3,12 €
Cap. Boursière
248,44 M
Fourchette du Jour
3,08 € — 3,20 €
Fourchette 52 Semaines
1,35 € — 4,60 €
Volume
710 681
Ouverture 3,09 €
Moyenne 50J / 200J
2,52 €
23,82% above
Moyenne 50J / 200J
2,57 €
21,45% above

Quick Summary

Points Clés

Negative free cash flow of -62,34 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-106,46%
En dessous de la moyenne du secteur (-53,41%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio6,74
Interest CoverageN/A

Valorisation

PE (TTM)
-5,45
En dessous de la moyenne du secteur (-1,48)
P/B Ratio7,03
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -5,5 -1,5
P/B 7,0 1,6
ROE % -106,5 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,01% weight
IRSSX IRSSX
0,01% weight
VVICX VVICX
0,00% weight
IRSIX IRSIX
0,00% weight
IIRSX IIRSX
0,00% weight
IRCIX IRCIX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -45,62 M
ROE -106,46% ROA -33,20%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -62,34 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,74
Interest Coverage N/A Asset Turnover N/A
Working Capital 82,01 M Tangible Book Value 35,36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5,45 Forward P/E N/A
P/B Ratio 7,03 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -25,09%
Market Cap 248,44 M Enterprise Value 244,77 M
Per Share
EPS (Diluted TTM) -0,52 Revenue / Share N/A
FCF / Share -0,78 OCF / Share -0,78
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 136,66%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -45,62 M -36,18 M -40,33 M -87,97 M -34,51 M
EPS (Diluted) -0,52 -0,75 -1,64 -6,16 —
Gross Profit — — — — —
Operating Income — — -43,00 M -88,43 M -36,87 M
EBITDA — — — — —
R&D Expenses 66,27 M 51,96 M 30,31 M 27,08 M 23,74 M
SG&A Expenses — — — — —
D&A — — — — 5 000,0
Interest Expense — — — — —
Income Tax 35 000,0 431 000,0 0,0 0,0 -2,35 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 169,01 M 177,41 M 89,07 M 92,79 M 170,55 M
Total Liabilities 32,23 M 59,27 M 5,65 M 8,61 M 6,55 M
Shareholders' Equity 81,09 M 118,14 M 83,42 M 84,18 M 164,00 M
Total Debt — — — — —
Cash & Equivalents 22,81 M 20,55 M 4,61 M 56,41 M 84,83 M
Current Assets 135,69 M 143,73 M 56,13 M 59,52 M 88,35 M
Current Liabilities 18,34 M 11,58 M 3,90 M 6,48 M 4,40 M